BeginnerSelf-pacedNo New Dates

Intoxication and Dissociation in Psychedelic-Assisted Therapy

Intoxication & Dissociation in Psychedelic-Assisted Therapy is a two-hour introductory course aimed at exploring the potential benefits and drawbacks of the utilization of psychedelic substances in therapy.

Provider

Fluence

English

Schedule

1 hour

Enrollment

$25

Course Overview

Intoxication & Dissociation in Psychedelic-Assisted Therapy is a two-hour introductory course aimed at exploring the potential benefits and drawbacks of the utilization of psychedelic substances in therapy. The course challenges the long-standing assumption that states of intoxication and dissociation in psychedelic therapy are harmful to mental health. Instead, it examines their role in a potentially therapeutic process.

Participants will learn about the state of intoxication in psilocybin-assisted therapy models and how dissociative states during psychedelic experiences can be therapeutic. They will also compare and contrast dissociative states to psychedelic states and gain a deeper understanding of how psychedelic therapy works. This knowledge will help to advance the integration of psychedelic therapy into mainstream psychiatric and psychological discourse.

This course is designed for healthcare professionals, mental health practitioners, and those interested in exploring the potential benefits of psychedelic therapy. It will provide an overview of the current research and understanding of intoxication and dissociation in psychedelic therapy and equip participants with the knowledge needed to make informed decisions in their practice.

Who is this for?

Healthcare professionals, mental health practitioners, and those interested in exploring the potential benefits of psychedelic therapy.

About the Provider

Fluence is a psychedelic therapy education company co-founded by psychologists Dr. Ingmar Gorman and Dr. Elizabeth Nielson, offering continuing education courses and a Certificate in Psychedelic Therapy and Integration for licensed therapists and advanced graduate students. Having trained 8,000+ clinicians, Fluence draws on its founders' direct experience in FDA-approved Phase 3 clinical trials of MDMA- and psilocybin-assisted therapies.

Related Courses

View all courses